+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

France Synthetic Biology Market 2019-2025

  • PDF Icon


  • February 2020
  • Region: France
  • Orion Market Research Private Limited
  • ID: 5116666
France Synthetic Biology Market Size, Share & Trends Analysis Report, By Product (Enabling Product, Core Product, and Enabled Product), By Technologies (Gene Synthesis & Sequencing, Genome Engineering, Bioinformatics, and Others), By Application (Medical Application, Industrial Application, Food & Agriculture, and Environmental Applications) and Forecast Period 2019-2025.

The France synthetic biology market is anticipated to grow at the CAGR of around 33.0% during the forecast period. Major opportunities for the France synthetic biology market is the presence of numerous companies and specially related to synthetic bio-fuels. Number of companies and start-ups are working toward synthetic biology including Global Bioenergies, DNA Script, Deinove and Fermentalg. Some other major companies are Deinove and Fermentalg which have a major market share in the country. Deinove had built a metabolic engineering platform which is based on bacteria Deinococcus. The bacteria are able to repair its genome once broken. The company valued more than $44 million in 2014.

The France synthetic biology market is segmented on the basis of product, technology, and applications. Based on the product, the market is segmented into enabling product, core product, and enabled product. Core product includes synthetic genes, synthetic cells, synthetic DNA, chassis organisms and xeno nucleic acid (XNA), and are expected to hold a significant share in the market owing to extensive use of core products in R&D. Based on technology, the market is segmented into, and gene synthesis & sequencing, genome engineering, bioinformatics, and others. Based on application, the market is segmented into medical application, industrial application, food & agriculture, and environmental applications.

The report study of the France synthetic biology industry includes the competitive analysis of various players as well as the trend followed by them to sustain in the market. Some of the players operating in the market include Twist Bioscience Corp., Merck KGaA, GenScript Biotech Corp., Thermo Fisher Scientific Inc., Amyris Inc., Codexis Inc, Ginkgo Bioworks, and many others. These players are focusing on agreements along with new product launches for expanding their business.

Research Methodology:

The market study of the France synthetic biology is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity in our reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for pharmaceutical companies, drug manufacturers, biotechnology companies, chemical and biofuel industry, academic and government research institutes, food and agriculture industries, potential investors and venture capitalists, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, products offered by the company, and future market opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation:

1. France Synthetic Biology Market Research and Analysis by Product.
2. France Synthetic Biology Market Research and Analysis by Technology.
3. France Synthetic Biology Market Research and Analysis by Application.

The Report Covers:
  • Comprehensive Research Methodology of the France synthetic biology market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the France synthetic biology market.
  • Insights about market determinants which are stimulating the France synthetic biology market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Algenol
  • Autolus Therapeutics PLC
  • Butamax Advanced Biofuels LLC
  • Desktop Genetics, Ltd.
  • E. I. du Pont de Nemours and Co.
  • GenScript Biotech Corp.
  • LGC, Ltd.
  • Merck KGaA
  • OriGene Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Twist Bioscience Corp.